Detalles de la búsqueda
1.
Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
Pediatr Infect Dis J
; 38(10): 1061-1067, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31469776
2.
Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4-6-year-old Girls: Results to Month 12 From a Randomized Trial.
Pediatr Infect Dis J
; 37(4): e93-e102, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29424799
Resultados
1 -
2
de 2
1
Próxima >
>>